4//SEC Filing
Shields Matthew 4
Accession 0000950170-24-069074
CIK 0000818686other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 7:25 AM ET
Size
5.9 KB
Accession
0000950170-24-069074
Insider Transaction Report
Form 4
Shields Matthew
EVP, Global Operations
Transactions
- Award
Restricted Share Units
2024-06-03+64,782→ 64,782 total→ Ordinary Shares (64,782 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on June 3, 2024, with 16,195 vesting on each of June 3, 2025, June 3, 2026 and June 3, 2027, and 16,197 vesting on June 3, 2028.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0002025621
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 7:25 AM ET
- Size
- 5.9 KB